Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

HoxB9 promotes the migration and invasion via TGF-β1/Smad2/Slug signaling pathway in oral squamous cell carcinoma.

Xue M, Zhu FY, Chen L, Wang K.

Am J Transl Res. 2017 Mar 15;9(3):1151-1161. eCollection 2017.

2.

Association between three functional microRNA polymorphisms (miR-499 rs3746444, miR-196a rs11614913 and miR-146a rs2910164) and breast cancer risk: a meta-analysis.

Zhang H, Zhang Y, Yan W, Wang W, Zhao X, Ma X, Gao X, Zhang S.

Oncotarget. 2017 Jan 3;8(1):393-407. doi: 10.18632/oncotarget.13426.

3.

Dynamic Pattern of HOXB9 Protein Localization during Oocyte Maturation and Early Embryonic Development in Mammals.

Sauvegarde C, Paul D, Bridoux L, Jouneau A, Degrelle S, Hue I, Rezsohazy R, Donnay I.

PLoS One. 2016 Oct 31;11(10):e0165898. doi: 10.1371/journal.pone.0165898. eCollection 2016.

4.

PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.

Wan J, Xu W, Zhan J, Ma J, Li X, Xie Y, Wang J, Zhu WG, Luo J, Zhang H.

Nucleic Acids Res. 2016 Dec 15;44(22):10662-10675. Epub 2016 Sep 8.

5.

The function of homeobox genes and lncRNAs in cancer.

Wang Y, Dang Y, Liu J, Ouyang X.

Oncol Lett. 2016 Sep;12(3):1635-1641. Epub 2016 Jul 21.

6.

Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile.

Zhang M, Li H, Zou D, Gao J.

Onco Targets Ther. 2016 May 5;9:2717-23. doi: 10.2147/OTT.S92529. eCollection 2016.

7.

Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo.

Deb P, Bhan A, Hussain I, Ansari KI, Bobzean SA, Pandita TK, Perrotti LI, Mandal SS.

Gene. 2016 Sep 30;590(2):234-43. doi: 10.1016/j.gene.2016.05.009. Epub 2016 May 13.

PMID:
27182052
8.

HOXC9 Induces Phenotypic Switching between Proliferation and Invasion in Breast Cancer Cells.

Hur H, Lee JY, Yang S, Kim JM, Park AE, Kim MH.

J Cancer. 2016 Apr 10;7(7):768-73. doi: 10.7150/jca.13894. eCollection 2016.

9.

HOX transcription factors are potential targets and markers in malignant mesothelioma.

Morgan R, Simpson G, Gray S, Gillett C, Tabi Z, Spicer J, Harrington KJ, Pandha HS.

BMC Cancer. 2016 Feb 11;16:85. doi: 10.1186/s12885-016-2106-7.

10.

GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.

Kwon OS, Oh E, Park JR, Lee JS, Bae GY, Koo JH, Kim H, Choi YL, Choi YS, Kim J, Cha HJ.

Oncotarget. 2015 Dec 8;6(39):41916-28. doi: 10.18632/oncotarget.6019.

11.

HOXB9 induction of mesenchymal-to-epithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif.

Chang Q, Zhang L, He C, Zhang B, Zhang J, Liu B, Zeng N, Zhu Z.

Oncotarget. 2015 Dec 15;6(40):42838-53. doi: 10.18632/oncotarget.5814.

12.

Hoxc8 initiates an ectopic mammary program by regulating Fgf10 and Tbx3 expression and Wnt/β-catenin signaling.

Carroll LS, Capecchi MR.

Development. 2015 Dec 1;142(23):4056-67. doi: 10.1242/dev.128298. Epub 2015 Oct 12.

13.

Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.

Basu M, Bhattacharya R, Ray U, Mukhopadhyay S, Chatterjee U, Roy SS.

Mol Cancer. 2015 Aug 23;14:162. doi: 10.1186/s12943-015-0433-y.

14.

JNK-dependent gene regulatory circuitry governs mesenchymal fate.

Sahu SK, Garding A, Tiwari N, Thakurela S, Toedling J, Gebhard S, Ortega F, Schmarowski N, Berninger B, Nitsch R, Schmidt M, Tiwari VK.

EMBO J. 2015 Aug 13;34(16):2162-81. doi: 10.15252/embj.201490693. Epub 2015 Jul 8.

15.

Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.

Oliveira-Costa JP, de Carvalho AF, da Silveira da GG, Amaya P, Wu Y, Park KJ, Gigliola MP, Lustberg M, Buim ME, Ferreira EN, Kowalski LP, Chalmers JJ, Soares FA, Carraro DM, Ribeiro-Silva A.

Oncotarget. 2015 Aug 28;6(25):20902-20.

16.

HOXB5 Promotes the Proliferation and Invasion of Breast Cancer Cells.

Lee JY, Hur H, Yun HJ, Kim Y, Yang S, Kim SI, Kim MH.

Int J Biol Sci. 2015 May 1;11(6):701-11. doi: 10.7150/ijbs.11431. eCollection 2015.

17.

The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.

Darda L, Hakami F, Morgan R, Murdoch C, Lambert DW, Hunter KD.

PLoS One. 2015 Apr 10;10(4):e0122285. doi: 10.1371/journal.pone.0122285. eCollection 2015.

18.
19.

HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.

Liu S, Jin K, Hui Y, Fu J, Jie C, Feng S, Reisman D, Wang Q, Fan D, Sukumar S, Chen H.

Cancer Res. 2015 Feb 15;75(4):709-19. doi: 10.1158/0008-5472.CAN-14-3100. Epub 2014 Dec 26.

20.

miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7.

Zhang R, Leng H, Huang J, Du Y, Wang Y, Zang W, Chen X, Zhao G.

Diagn Pathol. 2014 Sep 3;9:171. doi: 10.1186/s13000-014-0171-2.

Supplemental Content

Support Center